Regions On Rise: Life Sciences Across US
Pharmaceutical Commerce
AUGUST 11, 2022
Exploring the competitive and unique offerings in three of the US’s lower-cost economic development regions—and how success in these areas has been boosted by COVID.
regions-on-rise-life-sciences-across-us 
105 
Strengthening and transforming the pharmaceutical supply chain
European Pharmaceutical Review
JULY 21, 2023
Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. Globalisation and supply chain complexity are a factor.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
David Pendlebury, Head of Research Analysis, Institute for Scientific Information Shares Insights from its Annual Highly Cited Researchers List
PharmaShots
MAY 29, 2023
The annual list is based on data from the Web of Science™ citation index, together with analysis performed by bibliometric experts and data scientists at the Institute for Scientific Information (ISI)™ at Clarivate. Smriti: Can we first talk about the methodology which was used to create this list? are from just 10 and 71.4%
Top tweets: Covid-19 headed towards seasonality – and more
Pharmaceutical Technology
JULY 22, 2022
Muge Cevik’s tweet on the rise of unusual paediatric hepatitis cases. Helen Branswell’s tweet on the first US monkeypox case. Helen Branswell’s tweet on the first US monkeypox case. The top tweets on infectious diseases in Q2 2022: Top five. Laurie Garrett’s tweet on Covid-19 headed towards seasonality. Username: Laurie Garrett.
Hollywood and the Metaverse’s effect on pharma’s content
pharmaphorum
OCTOBER 3, 2022
“One of our senior clients in big pharma told us, ‘We don’t make pills. Indegene focuses on helping pharma launch its products using technology and compliance frameworks to become 100% compliant, Kapoor explains. “TV used to be very brand-centric. Nobody buys pills. Patients buy stories.
Combating antimicrobial resistance with a viable alternative to traditional antibiotics
pharmaphorum
JUNE 9, 2022
million 1 people per year and projected to rise to 10 million people by 2050 2. In its Strategic Priorities on AMR , the WHO made clear that “unless we act now, common diseases will become untreatable and modern life-saving procedures riskier to perform” as AMR proliferates.
USAID on expanding digital health globally – part two
pharmaphorum
MAY 23, 2022
Alliances have proven to be significant catalysts for change in regions of the world where digital health is either needed or in need of expansion. million of US government funding, specifically for digital connectivity infrastructure and digital financial services. Collaborative results. Pharma’s role.
Let's personalize your content